
We Go Together: Johnson & Johnson on talent clusters, biotech innovation and venture capital flows in Life Sciences
The Weekly Take from CBRE
00:00
Drug design trends, cost of drug development, and balancing safety with earlier approvals
This chapter explores the evolution of drug design, including the use of technology and AI. It also delves into the cost of drug development, the lessons learned from COVID vaccine approval, the significance of clinical trials, and the challenge of balancing safety with faster approvals.
Transcript
Play full episode